Latest news

• Givlaari, Rybelsus lead crowded CHMP recommendations

  The CHMP also recommended PaxVax’s cholera vaccine Vaxchora for prophylaxis against choleam and Eli Lilly’s new fast-acting mealtime insulin Liumjev, to improve glycemic control in diabetes in adults.

• The power of pharma businesses to drive social change

  Our research teams are collaborating with peers from organisations around the world to help in the development of effective treatments for diseases such as Chagas, cholera, dengue fever and schistosomiasis.

• FDA approves first cholera vaccine in US

  The approval also comes against the backdrop of a worldwide shortage in oral cholera vaccines, which include Valneva's Dukoral and the International Vaccine Institute's Shanchol. ... It is a live attenuated vaccine, incorporating a weakened strain of the

• Sanofi enters vaccines partnership with Sutro

  Sanofi Pasteur's vaccines currently cover 20 infectious diseases, including tuberculosis, cholera, influenza and hepatitis, and it is currently investigating a product to protect against the dengue virus.

• J&J to buy remaining shares in Crucell

  as hepatitis, influenza, typhoid and cholera.